+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Bioidentical Hormones Market by Product (Creams & Gels, Injectable, Patches & Implants), Hormones Type (Estrogens, Progesterone, Testosterone), End User - Forecast 2024-2030- Product Image
Global Bioidentical Hormones Market by Product (Creams & Gels, Injectable, Patches & Implants), Hormones Type (Estrogens, Progesterone, Testosterone), End User - Forecast 2024-2030- Product Image
Sale

Global Bioidentical Hormones Market by Product (Creams & Gels, Injectable, Patches & Implants), Hormones Type (Estrogens, Progesterone, Testosterone), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336236
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioidentical Hormones Market size was estimated at USD 493.45 million in 2023, USD 616.46 million in 2024, and is expected to grow at a CAGR of 25.02% to reach USD 2,356.01 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bioidentical Hormones Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bioidentical Hormones Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bioidentical Hormones Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayers AG, Biote Medical, LLC, Defy Medical, LLC, Full Life Wellness Center, Merck KGaA, NextGenRx Compounding Pharmacy, Novartis AG, Noven Pharmaceuticals, Inc. Hisamitsu Group, Novo Nordisk A/S, Nueva Aesthetics, Optimal Health and Wellness, Pavilion Compounding Pharmacy, LLC, Pellecome, LLC, Pfizer Inc., Schwietermans Pharmacy, The Biostation, and TherapeuticsMD, Inc.

Market Segmentation & Coverage

This research report categorizes the Bioidentical Hormones Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Creams & Gels
    • Injectable
    • Patches & Implants
    • Tablets & Capsules
  • Hormones Type
    • Estrogens
    • Progesterone
    • Testosterone
  • End User
    • Academic & Research Institutes
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Bioidentical Hormones Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bioidentical Hormones Market?
  3. What are the technology trends and regulatory frameworks in the Bioidentical Hormones Market?
  4. What is the market share of the leading vendors in the Bioidentical Hormones Market?
  5. Which modes and strategic moves are suitable for entering the Bioidentical Hormones Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bioidentical Hormones Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing screening for hormonal deficiency
5.1.1.2. Prevalence of hormonal deficiency in the population
5.1.1.3. Rise in geriatric population
5.1.2. Restraints
5.1.2.1. Varying side effects such as blurred vision or risk of breast cancer and heart attack
5.1.3. Opportunities
5.1.3.1. Concentration of major research companies in the developed countries
5.1.3.2. Formulation of customized hormonal therapy for specific patients
5.1.4. Challenges
5.1.4.1. Lack of quality control on purity and safety of the product compared to synthetic hormone products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Bioidentical Hormones Market, by Product
6.1. Introduction
6.2. Creams & Gels
6.3. Injectable
6.4. Patches & Implants
6.5. Tablets & Capsules
7. Bioidentical Hormones Market, by Hormones Type
7.1. Introduction
7.2. Estrogens
7.3. Progesterone
7.4. Testosterone
8. Bioidentical Hormones Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Clinics
9. Americas Bioidentical Hormones Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bioidentical Hormones Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bioidentical Hormones Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Bayers AG
13.1.3. Biote Medical, LLC
13.1.4. Defy Medical, LLC
13.1.5. Full Life Wellness Center
13.1.6. Merck KGaA
13.1.7. NextGenRx Compounding Pharmacy
13.1.8. Novartis AG
13.1.9. Noven Pharmaceuticals, Inc. Hisamitsu Group
13.1.10. Novo Nordisk A/S
13.1.11. Nueva Aesthetics
13.1.12. Optimal Health and Wellness
13.1.13. Pavilion Compounding Pharmacy, LLC
13.1.14. Pellecome, LLC
13.1.15. Pfizer Inc.
13.1.16. Schwietermans Pharmacy
13.1.17. The Biostation
13.1.18. TherapeuticsMD, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BIOIDENTICAL HORMONES MARKET RESEARCH PROCESS
FIGURE 2. BIOIDENTICAL HORMONES MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOIDENTICAL HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOIDENTICAL HORMONES MARKET DYNAMICS
FIGURE 7. BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2023 VS 2030 (%)
FIGURE 10. BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOIDENTICAL HORMONES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BIOIDENTICAL HORMONES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIOIDENTICAL HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOIDENTICAL HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOIDENTICAL HORMONES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. BIOIDENTICAL HORMONES MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOIDENTICAL HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOIDENTICAL HORMONES MARKET SIZE, BY PATCHES & IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIOIDENTICAL HORMONES MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 11. BIOIDENTICAL HORMONES MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BIOIDENTICAL HORMONES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOIDENTICAL HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. BIOIDENTICAL HORMONES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIOIDENTICAL HORMONES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BIOIDENTICAL HORMONES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. THAILAND BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY HORMONES TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOIDENTICAL HORMONES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. BIOIDENTICAL HORMONES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. BIOIDENTICAL HORMONES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. BIOIDENTICAL HORMONES MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Bayers AG
  • Biote Medical, LLC
  • Defy Medical, LLC
  • Full Life Wellness Center
  • Merck KGaA
  • NextGenRx Compounding Pharmacy
  • Novartis AG
  • Noven Pharmaceuticals, Inc. Hisamitsu Group
  • Novo Nordisk A/S
  • Nueva Aesthetics
  • Optimal Health and Wellness
  • Pavilion Compounding Pharmacy, LLC
  • Pellecome, LLC
  • Pfizer Inc.
  • Schwietermans Pharmacy
  • The Biostation
  • TherapeuticsMD, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 616.46 Million
Forecasted Market Value ( USD ) by 2030 $ 2356.01 Million
Compound Annual Growth Rate25.0%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 220 Pages
  • Global
Bioidentical Hormones Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Bioidentical Hormones Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Bioidentical Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Bioidentical Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 178 Pages
  • Global
From
Global Bioidentical Hormones Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Bioidentical Hormones Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 233 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From

About the Bioidentical Hormones Market

Bioidentical hormones are biotechnological products that are chemically identical to hormones naturally produced by the human body. They are used to treat a variety of medical conditions, including menopause, andropause, and hormone imbalances. Bioidentical hormones are typically derived from plant sources, such as yams and soybeans, and are then synthesized in a laboratory to create a product that is identical to the hormones produced by the body. Bioidentical hormones are becoming increasingly popular due to their ability to provide relief from symptoms associated with hormone imbalances without the side effects associated with traditional hormone replacement therapies. They are also seen as a more natural alternative to synthetic hormones. The bioidentical hormones market is growing rapidly, driven by increasing awareness of the benefits of bioidentical hormones and the availability of more affordable products. The market is expected to continue to grow in the coming years as more people become aware of the potential benefits of bioidentical hormones. Some companies in the bioidentical hormones market include BioTE Medical, BHRT Solutions, and Compounding Solutions. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.